Trial intelligence / Profile preview

Losartan in Repaired Coarctation of Aorta

NCT06150560Phase 3Recruiting

Sponsor
Mayo Clinic
Start
Apr 2024
Primary completion
Jun 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of losartan in Coarctation of the aorta (CoA), hypertension (HTN), sponsored by Mayo Clinic. Started Apr 2024; status: recruiting.

02

Drugs

losartan
03

Conditions

Coarctation of the aorta (CoA)hypertension (HTN)

Beyond the preview

Go deeper on NCT06150560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06150560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call